Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 237

The DOI matches its Crossref record.

Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural Mesothelioma: Results in 120 Consecutive Patients

Open access
Sugarbaker, David J., Garcia, Jose P., Richards, William G., Harpole, David H., Healy-Baldini, Elizabeth, DeCamp, Malcolm M., Mentzer, Steven J., Liptay, Michael J., Strauss, Gary M., Swanson, Scott J.·1996·Annals of Surgery

Abstract

OBJECTIVE: The authors examine the feasibility and efficacy of trimodality therapy in the treatment of malignant pleural mesothelioma and identify prognostic factors. BACKGROUND: Mesothelioma is a rare, uniformly fatal disease that has increased in incidence in recent decades. Single and bimodality therapies do not improve survival. METHODS: From 1980 to 1995, 120 patients underwent treatment for pathologically confirmed malignant mesothelioma at Brigham and Women's Hospital and Dana-Farber Cancer Institute (Boston, MA). Initial patient evaluation was performed by a multimodality team. Patients meeting selection criteria and with resectable disease identified by computed tomography scan or magnetic resonance imaging underwent extrapleural pneumonectomy followed by combination chemotherapy and radiotherapy. RESULTS: The cohort included 27 women and 93 men with a mean age of 56 years. Operative mortality rate was 5.0%, with a major morbidity rate of 22%. Overall survival rates were 45% at 2 years and 22% at 5 years. Two and 5-year survival rates were 65% and 27%, respectively, for patients with epithelial cell type, and 20% and 0%, respectively, for patients with sarcomatous or mixed histology tumors. Nodal involvement was a significant negative prognostic factor. Patients who were node negative with epithelial histology had 2- and 5-year survival rates of 74% and 39%, respectively. Involvement of margins at time of resection did not affect survival, except in the case of full-thickness, transdiaphragmatic invasion. Classification on the basis of a revised staging system stratified median survivals, which were 22, 17, and 11 months for stages I, II, and III, respectively (p = 0.04). CONCLUSIONS: Extrapleural pneumonectomy with adjuvant therapy is appropriate treatment for selected patients with malignant mesothelioma selected using a revised staging system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000658-199609000-00005

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 237

Metadata

Authors
Sugarbaker, D. J., Garcia, J. P., Richards, W. G., Harpole, D. H., Healy-Baldini, E., DeCamp, M. M., Mentzer, S. J., Liptay, M. J., Strauss, G. M., & Swanson, S. J.
Venue
Annals of Surgery
Published
1996-09
Volume
224
Issue
3
Pages
288-296
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2027384041
Cited by
237
References
0
FWCI
7.70
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural Mesothelioma: Results in 120 Consecutive Patients. https://app.cochat.ai/papers/10.1097/00000658-199609000-00005
The paper
Sugarbaker, D. J., Garcia, J. P., Richards, W. G., Harpole, D. H., Healy-Baldini, E., DeCamp, M. M., Mentzer, S. J., Liptay, M. J., Strauss, G. M., & Swanson, S. J. (1996). Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural Mesothelioma: Results in 120 Consecutive Patients. Annals of Surgery. https://doi.org/10.1097/00000658-199609000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.